Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 147 for

Edit search filters
  1. A Study to Assess Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease

    Scottsdale/Phoenix, AZ

  2. Validation of Pediatric Inflammatory Bowel Disease Knowledge Questions (Emma)

    Rochester, MN, Scottsdale/Phoenix, AZ

  3. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

    Rochester, MN

  4. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

    Scottsdale/Phoenix, AZ

  5. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

    Rochester, MN

  6. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

    Rochester, MN

  7. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)

    La Crosse, WI

  8. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

    Jacksonville, FL

  9. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

    Scottsdale/Phoenix, AZ

  10. A Study Comparing the Addition of Structured Psychosocial Care versus Standard of Care to the Treatment of Patients with Inflammatory Bowel Disease

    Rochester, MN

.

Mayo Clinic Footer